← Eichor
Study identifier: NCT06645691 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Hyperpolarized MR Imaging with Carbon-13 Pyruvate in the Human Body

Condition: Heart Failure · Cardiometabolic Syndrome · Cancer Diagnosis  ·  Sponsor: National Heart Centre Singapore

PhasePhase 2
Planned participants200
Who can joinAll sexes, 21 Years to 99 Years
Healthy volunteersYes

About this study

Positron emission tomography with 18F fluorodeoxyglucose (FDG) is the conventional imaging technique to provide information regarding tissue glucose uptake and has been highly clinically successful. However, it cannot assess downstream metabolism, which may be useful in the diagnosis and assessment of treatment response in a variety of diseases. Patients will also be exposed to ionizing radiation, the amount of exposure can vary depending on the dose of tracer administered, frequency of scans and duration of each scan. Carbon-13 (13C) magnetic resonance imaging (MRI) is particularly attractive for metabolic imaging because carbon serves as the backbone of nearly all organic molecules in the body. With this technique, the polarization increases to approximately 30%-40%, an increase of over 10,000 to 100,000-fold, thereby dramatically increasing the MRI signal . Whilst the role of 13C imaging has been demonstrated in many sites around the world, we aim to demonstrate the feasibility and application of 13C hyperpolarized imaging in healthy Singapore residents and patients with cardiovascular and/or cardiometabolic diseases.

This description comes directly from the study's public registry record.

Talk to the study team

Calvin WL Chin  ·  6568449055  ·  CAMI@nhcs.com.sg

Always discuss trial participation with your own doctor first.

Locations (1)

National Heart Centre SingaporeSingapore, SingaporeRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06645691